To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SAV1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
374 supporting clones for gene SAV1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BI550772 brain, hippocampus .a 1 to 745 5 to 743   tiling clone,   743/892
(83 %)
11 diff
(98.8 %id)
BI550855 brain, hippocampus .a 1 to 843 5 to 847       847/924
(91 %)
16 diff
(98.3 %id)
TI_44172190   .a 1 to 843 124 to 966       844/1043
(80 %)
16 diff
(98.5 %id)
AL833378 lymph node .a 414 to 3445 1 to 3032   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 3032/3032
(100 %)
0 diff
(100 %id)
Z21409   .a 1322 to 1592 263 to 1       263/280
(93 %)
11 diff
(96.1 %id)
AW242510 Kidney .a 1327 to 1870 550 to 6       545/550
(99 %)
0 diff
(100 %id)
CB145986 Liver .a 1328 to 1870 544 to 2     Submitted on the opposite strand 543/544
(99 %)
0 diff
(100 %id)
BF114668 pooled .a 1341 to 1858 524 to 5       520/524
(99 %)
0 diff
(100 %id)
BE178047 head_neck .a 1354 to 1868 1 to 514       514/518
(99 %)
15 diff
(97.2 %id)
AW361907 colon .a 1360 to 1741 382 to 1       382/382
(100 %)
10 diff
(97.4 %id)
AA829947 germinal center B cell .a 1360 to 1868 520 to 12   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 509/509
(100 %)
0 diff
(100 %id)
DB521837 testis .a 1373 to 1863 1 to 492     Submitted on the opposite strand 492/492
(100 %)
3 diff
(99.4 %id)
BQ949048 sciatic nerve .a 1373 to 1871 1 to 501       501/520
(96 %)
2 diff
(99.7 %id)
DB521868 testis .a 1376 to 1863 1 to 489     Submitted on the opposite strand 489/489
(100 %)
8 diff
(98.4 %id)
DB542100 hippocampus .a 1388 to 1863 1 to 474     Submitted on the opposite strand 474/474
(100 %)
2 diff
(99.6 %id)
DB526713 testis .a 1393 to 1863 1 to 472     Submitted on the opposite strand 472/472
(100 %)
2 diff
(99.6 %id)
AA633268 colon, colon tumor RER+ .a 1394 to 1862 469 to 1       469/469
(100 %)
2 diff
(99.6 %id)
AI742389 pooled .a 1395 to 1862 468 to 1       468/468
(100 %)
1 diff
(99.8 %id)
DB526728 testis .a 1409 to 1863 1 to 456     Submitted on the opposite strand 456/456
(100 %)
2 diff
(99.6 %id)
DB549753 hippocampus .a 1409 to 1867 1 to 460     Submitted on the opposite strand 460/461
(99 %)
5 diff
(99.0 %id)
DB523794 testis .a 1410 to 1860 1 to 451     Submitted on the opposite strand 451/453
(99 %)
2 diff
(99.6 %id)
DB520323 testis .a 1411 to 1863 1 to 453     Submitted on the opposite strand 453/453
(100 %)
0 diff
(100 %id)
AI358877 brain, glioblastoma (pooled) .a 1413 to 1863 454 to 1       454/454
(100 %)
7 diff
(98.5 %id)
DB525497 testis .a 1419 to 1863 1 to 445     Submitted on the opposite strand 445/445
(100 %)
0 diff
(100 %id)
AA810262 germinal center B cell .a 1425 to 1868 457 to 14   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 444/444
(100 %)
2 diff
(99.6 %id)
CD679189 eye, Trabecular meshwork .a 1436 to 1863 1 to 428   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 428/428
(100 %)
0 diff
(100 %id)
AI306420 2 pooled tumors (clear cell type), Kidney .a 1439 to 1865 427 to 1       427/427
(100 %)
1 diff
(99.8 %id)
AW237201 pooled germ cell tumors .a 1440 to 1870 432 to 1       432/432
(100 %)
6 diff
(98.7 %id)
AI077478 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1441 to 1868 446 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 428/428
(100 %)
1 diff
(99.8 %id)
AW008013 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1441 to 1863 445 to 22   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 424/424
(100 %)
8 diff
(98.2 %id)
AI702709 carcinoid, lung .a 1443 to 1864 443 to 21       423/443
(95 %)
0 diff
(100 %id)
H88558 cochlea, ear .a 1445 to 1870 1 to 428       428/428
(100 %)
15 diff
(96.5 %id)
AI078808 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1448 to 1868 439 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 421/421
(100 %)
1 diff
(99.8 %id)
AI307390 2 pooled tumors (clear cell type), Kidney .a 1452 to 1866 417 to 3       415/417
(99 %)
0 diff
(100 %id)
AI628420 Kidney .a 1455 to 1863 420 to 12   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 409/409
(100 %)
5 diff
(98.8 %id)
AI445691 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1457 to 1866 411 to 2       410/411
(99 %)
0 diff
(100 %id)
DB543756.
matches multiple genes
hippocampus .a 1473 to 1925 453 to 1     also hits gene ATL1 453/453
(100 %)
0 diff
(100 %id)
DB548416.
matches multiple genes
hippocampus .a 1473 to 1893 421 to 1     also hits gene ATL1 421/421
(100 %)
0 diff
(100 %id)
AA489497   .a 1495 to 1870 382 to 7     Submitted on the opposite strand 376/382
(98 %)
0 diff
(100 %id)
AI872173 ovary, tumor, 5 pooled (see description) .a 1500 to 1863 364 to 1       364/371
(98 %)
1 diff
(99.8 %id)
AA931751 2 pooled tumors (clear cell type), Kidney .a 1501 to 1866 367 to 2       366/367
(99 %)
0 diff
(100 %id)
AA993410   .a 1518 to 1826 309 to 1       309/309
(100 %)
0 diff
(100 %id)
AI082128 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1518 to 1868 369 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 351/351
(100 %)
0 diff
(100 %id)
AI093815 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1525 to 1863 339 to 1       339/339
(100 %)
0 diff
(100 %id)
AI186417 placenta .a 1530 to 1611 82 to 1       82/82
(100 %)
0 diff
(100 %id)
AI699115 carcinoid, lung .a 1535 to 1866 335 to 4       332/335
(99 %)
0 diff
(100 %id)
R45171 whole brain .a 1542 to 1863 340 to 14   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 327/330
(99 %)
10 diff
(97.0 %id)
FN071522 breast carcinoma .a 1564 to 1633 1 to 70       70/71
(98 %)
3 diff
(95.8 %id)
D62419   .a 1579 to 1865 23 to 309       287/311
(92 %)
2 diff
(99.4 %id)
FN162208 breast carcinoma .a 1606 to 1713 1 to 107       107/107
(100 %)
1 diff
(99.1 %id)
BE349346 malignant melanoma, metastatic to lymphnode, skin .a 1612 to 1863 252 to 1       252/252
(100 %)
0 diff
(100 %id)
FN063608 breast carcinoma .a 1681 to 1765 1 to 85       85/85
(100 %)
2 diff
(97.7 %id)
CN353660 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1706 to 1870 1 to 165       165/168
(98 %)
5 diff
(97.1 %id)
BG388692 embryonal carcinoma, cell line, testis .a 2006 to 2798 1 to 788       788/913
(86 %)
22 diff
(97.6 %id)
H88517 cochlea, ear .a 2059 to 2391 334 to 1       334/340
(98 %)
3 diff
(99.2 %id)
FN088858 breast carcinoma .a 2090 to 2200 1 to 110       110/110
(100 %)
4 diff
(96.4 %id)
DB537266.
matches multiple genes
hippocampus .a 2449 to 2860 414 to 1     also hits gene ATL1 414/416
(99 %)
5 diff
(98.8 %id)
DB537854.
matches multiple genes
hippocampus .a 2449 to 2876 431 to 1     also hits gene ATL1 431/433
(99 %)
5 diff
(98.9 %id)
DB546205 hippocampus .a 2466 to 2905 440 to 1       440/441
(99 %)
0 diff
(100 %id)
BU620974 cell lines, Chondrosarcoma .a 2540 to 3305 783 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 765/765
(100 %)
1 diff
(99.9 %id)
DB535150.
matches multiple genes
hippocampus .a 2599 to 3044 449 to 1     also hits gene ATL1 449/450
(99 %)
8 diff
(98.3 %id)
DB541429.
matches multiple genes
hippocampus .a 2599 to 3064 466 to 1     also hits gene ATL1 466/466
(100 %)
0 diff
(100 %id)
DB548245.
matches multiple genes
hippocampus .a 2599 to 3021 423 to 1     also hits gene ATL1 423/423
(100 %)
0 diff
(100 %id)
DB548304.
matches multiple genes
hippocampus .a 2599 to 3025 427 to 1     also hits gene ATL1 427/427
(100 %)
0 diff
(100 %id)
DB559171.
matches multiple genes
hypothalamus .a 2599 to 2995 398 to 1     also hits gene ATL1 398/398
(100 %)
1 diff
(99.8 %id)
DB510792.
matches multiple genes
testis .a 2833 to 3157 323 to 1     also hits gene ATL1 323/323
(100 %)
3 diff
(99.1 %id)
DB530249 hippocampus .a 2833 to 3143 315 to 1       315/315
(100 %)
14 diff
(95.6 %id)
DB534905.
matches multiple genes
hippocampus .a 2833 to 3273 441 to 1     also hits gene ATL1 441/441
(100 %)
4 diff
(99.1 %id)
DB535942.
matches multiple genes
hippocampus .a 2833 to 3272 446 to 1     also hits gene ATL1 446/446
(100 %)
9 diff
(98.0 %id)
DB537897 hippocampus .a 2833 to 3258 431 to 1       431/431
(100 %)
12 diff
(97.3 %id)
DB572846.
matches multiple genes
hypothalamus .a 2833 to 3278 452 to 7     also hits gene ATL1 446/452
(98 %)
0 diff
(100 %id)
DB539071 hippocampus .a 2834 to 3107 359 to 84       276/359
(76 %)
0 diff
(100 %id)
AA602162   .a 2902 to 3176 20 to 294       275/294
(93 %)
6 diff
(98.0 %id)
Z19747   .a 2946 to 3157 1 to 212       212/212
(100 %)
8 diff
(96.3 %id)
AV742702 cord Blood .b 1 to 385 394 to 23   tiling clone, AAA Submitted on the opposite strand 372/408
(91 %)
0 diff
(100 %id)
AF150221 umbilical cord blood .b 2 to 405 402 to 2   tiling clone,   401/402
(99 %)
0 diff
(100 %id)
TI_154089898   .b 40 to 618 642 to 63       580/643
(90 %)
0 diff
(100 %id)
AI831619 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 108 to 608 502 to 1   tiling clone,   502/502
(100 %)
9 diff
(98.3 %id)
DW421780 Liver .b 131 to 408 296 to 18       279/296
(94 %)
0 diff
(100 %id)
DW433151 Liver .b 197 to 408 230 to 18       213/263
(80 %)
0 diff
(100 %id)
DA712776   .b 252 to 590 2 to 339   tiling clone, capped   338/338
(100 %)
5 diff
(98.6 %id)
DB072936 testis .b 435 to 828 2 to 389   tiling clone, capped   388/388
(100 %)
4 diff
(99.0 %id)
AW450785   .b 440 to 617 177 to 1       177/187
(94 %)
3 diff
(98.4 %id)
TI_45216435   .b 601 to 1335 120 to 857       738/857
(86 %)
23 diff
(97.4 %id)
DB054951 testis .b 602 to 966 2 to 361   capped   360/360
(100 %)
3 diff
(99.2 %id)
DB056852 testis .b 602 to 897 2 to 297   capped   296/296
(100 %)
1 diff
(99.7 %id)
BI602690 brain, hypothalamus .b 603 to 1335 1 to 736       736/736
(100 %)
38 diff
(94.9 %id)
DA214718 brain .b 605 to 933 2 to 324   capped   323/323
(100 %)
2 diff
(99.4 %id)
DA536352 heart .b 605 to 1211 2 to 603   capped   602/602
(100 %)
3 diff
(99.6 %id)
BI460433 testis .b 612 to 1373 1 to 763       763/774
(98 %)
44 diff
(94.4 %id)
TI_44166672   .b 622 to 1297 81 to 750       670/752
(89 %)
10 diff
(98.7 %id)
DB216341 trachea .b 622 to 913 2 to 288   capped   287/287
(100 %)
4 diff
(98.7 %id)
DA488318 brain .b 623 to 1084 2 to 457   capped   456/456
(100 %)
2 diff
(99.6 %id)
DB460054 testis .b 623 to 1087 1 to 459       459/464
(98 %)
7 diff
(98.5 %id)
DR155569 human embryonic stem cells differentiated toan early endodermal cell type .b 623 to 1412 1 to 784       784/784
(100 %)
2 diff
(99.8 %id)
DA479812   .b 624 to 928 2 to 306   capped   305/305
(100 %)
0 diff
(100 %id)
DB472575 hippocampus .b 624 to 1122 1 to 494       494/494
(100 %)
7 diff
(98.6 %id)
DA516055 brain .b 625 to 919 2 to 292   capped   291/297
(97 %)
7 diff
(97.7 %id)
BI548884 brain, hippocampus .b 625 to 1297 1 to 667       667/669
(99 %)
10 diff
(98.6 %id)
DA485469 brain .b 626 to 909 2 to 279   capped   278/278
(100 %)
2 diff
(99.3 %id)
DA886623   .b 626 to 1168 2 to 538   capped   537/537
(100 %)
2 diff
(99.7 %id)
AK225896   .b 630 to 2576 1 to 1941 Q373*     1941/1941
(100 %)
7 diff
(99.7 %id)
DB474963 hippocampus .b 630 to 1136 1 to 501       501/501
(100 %)
4 diff
(99.3 %id)
BP242991 Liver .b 630 to 1212 1 to 579       579/580
(99 %)
16 diff
(97.3 %id)
DA015381 adrenal gland .b 631 to 1187 2 to 555   capped   554/554
(100 %)
7 diff
(98.8 %id)
BG703975 brain, hippocampus .b 632 to 1403 6 to 777       772/817
(94 %)
34 diff
(95.9 %id)
BI094070 cervix .b 632 to 1444 1 to 823       823/1064
(77 %)
34 diff
(96.9 %id)
DA017597 adrenal gland .b 633 to 909 2 to 272   capped   271/271
(100 %)
4 diff
(98.6 %id)
DA254573 caudate nucleus .b 635 to 1061 2 to 425   capped   424/424
(100 %)
7 diff
(98.4 %id)
DB454914 testis .b 635 to 1140 1 to 500       500/500
(100 %)
3 diff
(99.4 %id)
DA626214 Kidney .b 635 to 921 2 to 282   capped   281/281
(100 %)
2 diff
(99.3 %id)
AL517264 brain, neuroblastoma, neuroblastoma cells .b 645 to 1105 37 to 501       465/501
(92 %)
10 diff
(98.1 %id)
DB456452 testis .b 646 to 1157 1 to 506       506/506
(100 %)
6 diff
(98.9 %id)
BX358987 Placenta Cot 25-normalized .b 648 to 1660 1 to 1012       1012/1033
(97 %)
26 diff
(97.5 %id)
BG717144 testis .b 650 to 1350 1 to 697       697/698
(99 %)
8 diff
(98.9 %id)
BX464447 brain, neuroblastoma, neuroblastoma cells .b 651 to 1728 1 to 1062       1062/1070
(99 %)
43 diff
(96.0 %id)
AL552035 placenta, Placenta Cot 25-normalized .b 651 to 1531 1 to 874       874/1071
(81 %)
7 diff
(99.4 %id)
AK021500 whole embryo, mainly head .b 655 to 2484 1 to 1824 L292F available from FLJ,   1824/1824
(100 %)
5 diff
(99.8 %id)
DB473329 hippocampus .b 655 to 1154 1 to 494       494/494
(100 %)
6 diff
(98.8 %id)
BC020537 Kidney, hypernephroma .b 656 to 2485 1 to 1824 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1824/1824
(100 %)
6 diff
(99.7 %id)
DA229317 brain .b 656 to 1125 2 to 465   capped   464/464
(100 %)
3 diff
(99.4 %id)
AU117370 whole embryo, mainly head .b 656 to 1468 2 to 817   capped   816/833
(97 %)
18 diff
(97.9 %id)
NM_021818.2   .b 656 to 3686 1 to 3031 exact RefSeq,   3031/3031
(100 %)
0 diff
(100 %id)
DA766443 tongue .b 656 to 1073 2 to 413   capped   412/412
(100 %)
2 diff
(99.6 %id)
DA766515 tongue .b 656 to 964 2 to 310   capped   309/309
(100 %)
0 diff
(100 %id)
DB061335 testis .b 656 to 1207 2 to 553   capped   552/552
(100 %)
8 diff
(98.6 %id)
BI459285 testis .b 659 to 1087 1 to 428       428/730
(58 %)
12 diff
(98.4 %id)
BI604176 brain, hypothalamus .b 659 to 1387 1 to 728       728/728
(100 %)
21 diff
(97.2 %id)
CN337870 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 660 to 953 1 to 288       288/288
(100 %)
7 diff
(97.6 %id)
DB458298 testis .b 664 to 1147 1 to 478       478/478
(100 %)
3 diff
(99.4 %id)
DB473038.
matches multiple genes
hippocampus .b 664 to 1147 1 to 478     also hits gene ATL1 478/478
(100 %)
3 diff
(99.4 %id)
DB480944 hippocampus .b 664 to 1149 1 to 481       481/481
(100 %)
5 diff
(99.0 %id)
DB497586 hypothalamus .b 664 to 1176 1 to 507       507/507
(100 %)
5 diff
(99.1 %id)
CB995094 placenta, pre-eclamptic placenta .b 664 to 1297 28 to 677   tiling clone,   650/858
(75 %)
22 diff
(97.5 %id)
CB996961 placenta, pre-eclamptic placenta .b 664 to 1266 28 to 643       616/934
(65 %)
34 diff
(96.4 %id)
CB994249 placenta, pre-eclamptic placenta .b 664 to 924 28 to 288       261/290
(90 %)
6 diff
(98.0 %id)
TI_45213613   .b 664 to 1387 87 to 809       723/809
(89 %)
14 diff
(98.3 %id)
DA702362   .b 665 to 1142 2 to 474   capped   473/473
(100 %)
3 diff
(99.4 %id)
DB042008 testis .b 665 to 1211 2 to 545   capped   544/544
(100 %)
5 diff
(99.1 %id)
BE778302 eye, retinoblastoma .b 666 to 1347 1 to 690       690/1012
(68 %)
19 diff
(98.2 %id)
DB117919 thymus .b 666 to 1192 2 to 522   capped   521/521
(100 %)
2 diff
(99.7 %id)
BM546724 ovary (pool of 3) .b 667 to 1531 22 to 883       862/1076
(80 %)
17 diff
(98.5 %id)
DA246919 brain .b 669 to 1268 2 to 596   capped   595/595
(100 %)
3 diff
(99.5 %id)
DB077044 testis .b 669 to 1207 2 to 535   capped   534/534
(100 %)
4 diff
(99.3 %id)
AI005425 pooled .b 672 to 1035 1 to 358     Submitted on the opposite strand 358/358
(100 %)
2 diff
(99.5 %id)
AI086040 B-cell, chronic lymphotic leukemia .b 672 to 1024 1 to 347     Submitted on the opposite strand 347/347
(100 %)
2 diff
(99.5 %id)
BI490251 pooled brain, lung, testis .b 685 to 1603 1 to 912     Submitted on the opposite strand 912/939
(97 %)
23 diff
(97.6 %id)
CN337876 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 693 to 922 12 to 243       232/243
(95 %)
6 diff
(97.6 %id)
TI_43961299   .b 694 to 1235 57 to 600   fully sequenced, Submitted on the opposite strand 548/604
(90 %)
6 diff
(99.1 %id)
BG171875 hypernephroma, cell line, Kidney .b 698 to 1409 37 to 740       704/963
(73 %)
30 diff
(96.9 %id)
AK023071   .b 779 to 3686 1 to 2902 exact tiling clone, available from FLJ,   2902/2902
(100 %)
5 diff
(99.9 %id)
AU130248   .b 780 to 1419 2 to 644   capped   643/643
(100 %)
4 diff
(99.4 %id)
AA171865   .b 821 to 1224 14 to 410       397/410
(96 %)
10 diff
(97.6 %id)
DA717832   .b 874 to 1243 224 to 599   capped   512/598
(85 %)
19 diff
(96.9 %id)
DB077201 testis .b 890 to 1447 13 to 570   capped   558/569
(98 %)
6 diff
(99.0 %id)
AJ292969   .b 896 to 2960 69 to 2133 K5Q AAA Possibly primed on the genome, locally A rich (28/32 A in genome downstream of last aligned base) 2065/2135
(96 %)
15 diff
(99.3 %id)
CN337874 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 918 to 1629 1 to 712       712/712
(100 %)
0 diff
(100 %id)
DN990955 brain, whole brain .b 925 to 1643 1 to 722       725/722
(100 %)
5 diff
(99.4 %id)
CN337877 embryonic stem cells, DMSO-treated H9 cellline .b 955 to 1500 1 to 543       543/543
(100 %)
5 diff
(99.1 %id)
DB254137 uterus .b 962 to 1504 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
TI_1948124153   .b 992 to 1943 124 to 1087       961/1295
(74 %)
54 diff
(95.9 %id)
CR457297   .b 994 to 2143 1 to 1150       1150/1152
(99 %)
2 diff
(99.9 %id)
TI_1948124151   .b 994 to 1943 125 to 1075       951/1264
(75 %)
14 diff
(98.9 %id)
TI_1948124152   .b 994 to 1951 128 to 1081       954/1321
(72 %)
32 diff
(97.6 %id)
TI_1948124674   .b 994 to 1943 125 to 1076       952/1316
(72 %)
23 diff
(98.3 %id)
TI_1948125209   .b 994 to 2143 128 to 1278       1151/1282
(89 %)
67 diff
(94.8 %id)
TI_1948125210   .b 994 to 1943 126 to 1073       948/1334
(71 %)
23 diff
(98.3 %id)
TI_1948125739   .b 994 to 1955 122 to 1088       967/1272
(76 %)
29 diff
(97.8 %id)
TI_1948125740   .b 994 to 1939 126 to 1080       955/1373
(69 %)
25 diff
(98.2 %id)
TI_1948125741   .b 994 to 1847 134 to 995       862/1431
(60 %)
29 diff
(98.0 %id)
AA972007 pooled .b 1005 to 1417 413 to 1       413/413
(100 %)
0 diff
(100 %id)
CN337872 embryonic stem cells, DMSO-treated H9 cellline .b 1018 to 1476 1 to 460       460/460
(100 %)
2 diff
(99.6 %id)
TI_1948125743   .b 1074 to 2153 1183 to 120       1064/1339
(79 %)
52 diff
(96.2 %id)
TI_1948124678   .b 1078 to 2153 1189 to 119       1071/1348
(79 %)
59 diff
(95.7 %id)
TI_1948125213   .b 1082 to 2153 1186 to 120       1067/1371
(77 %)
48 diff
(96.5 %id)
BI489611 pooled brain, lung, testis .b 1089 to 1855 770 to 1     Submitted on the opposite strand 770/1050
(73 %)
13 diff
(98.8 %id)
CN337875 embryonic stem cells, DMSO-treated H9 cellline .b 1112 to 1567 1 to 457       457/457
(100 %)
4 diff
(99.2 %id)
CN337868 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1131 to 1854 1 to 723       723/723
(100 %)
3 diff
(99.6 %id)
TI_1948125744   .b 1134 to 2153 1142 to 120       1023/1389
(73 %)
42 diff
(97.0 %id)
CD630917   .b 1136 to 1591 454 to 1       454/469
(96 %)
2 diff
(99.6 %id)
CD630918   .b 1136 to 1592 30 to 494       465/495
(93 %)
7 diff
(98.6 %id)
TI_1948124155   .b 1139 to 2153 1137 to 120       1018/1356
(75 %)
36 diff
(97.4 %id)
TI_1948124679   .b 1139 to 2153 1130 to 119       1012/1389
(72 %)
58 diff
(95.9 %id)
CN337880 embryonic stem cells, cell lines H1, H7, andH9 .b 1143 to 1671 1 to 529       529/529
(100 %)
0 diff
(100 %id)
AU137307 placenta .b 1148 to 1796 2 to 655   capped   654/655
(99 %)
11 diff
(98.4 %id)
TI_1948124156   .b 1148 to 2153 1135 to 118       1018/1468
(69 %)
44 diff
(97.1 %id)
BU941090 mixed (pool of 40 RNAs) .b 1182 to 1946 1 to 768       768/798
(96 %)
15 diff
(98.2 %id)
BG167130 hypernephroma, cell line, Kidney .b 1189 to 1955 1 to 774       774/788
(98 %)
21 diff
(97.4 %id)
CN337879 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1193 to 1921 1 to 729       729/729
(100 %)
4 diff
(99.5 %id)
TI_43961298   .b 1205 to 1855 723 to 70   fully sequenced, Submitted on the opposite strand 654/723
(90 %)
1 diff
(99.9 %id)
N53743.
matches multiple genes
multiple sclerosis lesions .b 1264 to 1419 1 to 156     also hits gene NEDD8_ 156/156
(100 %)
0 diff
(100 %id)
TI_1948125214   .b 1270 to 2153 1000 to 119       882/1428
(61 %)
12 diff
(99.2 %id)
TI_1948124677   .b 1272 to 2153 1007 to 116       892/1297
(68 %)
31 diff
(97.7 %id)
TI_1948125212   .b 1310 to 2153 970 to 114       857/1327
(64 %)
30 diff
(97.8 %id)
BG622786 placenta .b 1324 to 2135 1 to 814       814/814
(100 %)
15 diff
(98.2 %id)
BG623511 placenta .b 1324 to 2098 1 to 781       781/1122
(69 %)
34 diff
(97.0 %id)
BG616685 Liver .b 1325 to 2105 1 to 786       786/786
(100 %)
12 diff
(98.5 %id)
TI_1948125742   .b 1326 to 2153 960 to 119       842/1409
(59 %)
22 diff
(98.5 %id)
TI_1948124154   .b 1327 to 2153 948 to 119       830/1265
(65 %)
13 diff
(99.0 %id)
DA538749 Kidney .b 1342 to 1913 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
CD630913   .b 1351 to 1590 240 to 1       240/255
(94 %)
2 diff
(99.3 %id)
CD630920   .b 1351 to 1586 236 to 1       236/251
(94 %)
0 diff
(100 %id)
CD630919   .b 1365 to 1592 1 to 228       228/229
(99 %)
2 diff
(99.2 %id)
BP290859 lung .b 1420 to 1938 1 to 519       519/583
(89 %)
36 diff
(93.9 %id)
AU128961   .b 1425 to 2205 2 to 794   capped   793/793
(100 %)
26 diff
(96.8 %id)
N41540 melanocyte .b 1449 to 1666 1 to 218       218/218
(100 %)
1 diff
(99.6 %id)
BI767525 pooled lung and spleen .b 1450 to 2004 150 to 703       554/703
(78 %)
7 diff
(99.1 %id)
TI_57184259   .b 1450 to 2004 180 to 733       554/733
(75 %)
7 diff
(99.1 %id)
BX327907 Placenta Cot 25-normalized .b 1466 to 2365 1 to 901       901/905
(99 %)
18 diff
(98.1 %id)
W55932 heart .b 1503 to 1887 1 to 388   fully sequenced,   388/388
(100 %)
4 diff
(99.0 %id)
BX327906 Placenta Cot 25-normalized .b 1527 to 2383 1 to 856       856/863
(99 %)
12 diff
(98.7 %id)
TI_154105485   .b 1527 to 2276 847 to 102   AAA   746/959
(77 %)
8 diff
(99.2 %id)
BG150410 carcinoid, lung .b 1550 to 1935 10 to 395     Submitted on the opposite strand 386/395
(97 %)
16 diff
(96.0 %id)
BG025433 lymph, lymphoma, cell line .b 1553 to 2272 1 to 722       722/1016
(71 %)
26 diff
(97.5 %id)
AI702956 carcinoid, lung .b 1558 to 2041 1 to 484     Submitted on the opposite strand 484/484
(100 %)
2 diff
(99.6 %id)
AA035751 uterus .b 1559 to 1937 1 to 382       382/397
(96 %)
7 diff
(98.3 %id)
AI679398 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 1606 to 2276 667 to 1       667/667
(100 %)
16 diff
(97.7 %id)
BG616274 embryonal carcinoma, testis .b 1607 to 2345 1 to 745       745/746
(99 %)
12 diff
(98.4 %id)
BG615424 embryonal carcinoma, testis .b 1607 to 2426 1 to 813       813/877
(92 %)
32 diff
(96.4 %id)
CA446654 Chondrosarcoma, Left Pubic Bone .b 1614 to 2276 681 to 19   AAA   663/663
(100 %)
1 diff
(99.9 %id)
BI762279 pooled colon, kidney, stomach .b 1691 to 2233 1 to 544       544/647
(84 %)
4 diff
(99.4 %id)
TI_57151502   .b 1691 to 2233 30 to 573       544/676
(80 %)
9 diff
(98.7 %id)
N29021 melanocyte .b 1699 to 2027 149 to 479       331/480
(68 %)
9 diff
(98.2 %id)
BQ232211 melanotic melanoma, skin .b 1700 to 2513 1 to 825   AAA   825/831
(99 %)
15 diff
(98.2 %id)
CX756574 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 1701 to 2403 1 to 701     Submitted on the opposite strand 701/701
(100 %)
14 diff
(98.1 %id)
CA309185 Alveolar Macrophage, lung .b 1750 to 2485 754 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 736/736
(100 %)
1 diff
(99.9 %id)
AA489498   .b 1758 to 2241 1 to 484     Submitted on the opposite strand 484/484
(100 %)
0 diff
(100 %id)
AW290872   .b 1766 to 2256 508 to 18   AAA   491/491
(100 %)
0 diff
(100 %id)
N51929.
matches multiple genes
multiple sclerosis lesions .b 1775 to 2254 479 to 1     also hits gene NEDD8_ 479/480
(99 %)
1 diff
(99.8 %id)
CV806818 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 1787 to 2485 1 to 699   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 699/699
(100 %)
6 diff
(99.2 %id)
BX330402 Placenta Cot 25-normalized .b 1797 to 2215 418 to 1       418/418
(100 %)
32 diff
(92.4 %id)
AI125901   .b 1805 to 2254 470 to 21   AAA   450/450
(100 %)
0 diff
(100 %id)
BE378132 endometrium, adenocarcinoma cell line, uterus .b 1805 to 2314 1 to 510       510/510
(100 %)
0 diff
(100 %id)
H43392 breast .b 1816 to 2339 1 to 522       522/522
(100 %)
14 diff
(97.4 %id)
BF246149 brain, glioblastoma .b 1830 to 2497 1 to 663       663/843
(78 %)
33 diff
(96.1 %id)
W55933 heart .b 1857 to 2260 412 to 6   fully sequenced,   407/412
(98 %)
0 diff
(100 %id)
BF382389 brain, primitive neuroectoderm .b 1857 to 2524 1 to 666       666/865
(76 %)
25 diff
(97.2 %id)
BM800538 leiomyosarcoma, uterus .b 1858 to 2724 1 to 869   tiling clone,   869/1056
(82 %)
15 diff
(98.6 %id)
AI638316 pooled germ cell tumors .b 1860 to 2258 399 to 1       399/399
(100 %)
1 diff
(99.8 %id)
AI650530 pooled germ cell tumors .b 1872 to 2254 405 to 23   AAA   383/383
(100 %)
4 diff
(99.0 %id)
BF032152 hypernephroma, Kidney .b 1877 to 2504 1 to 618       618/872
(70 %)
19 diff
(97.9 %id)
AW591967 pooled .b 1879 to 2256 393 to 16   AAA   378/386
(97 %)
0 diff
(100 %id)
AW104185 pooled .b 1880 to 2259 379 to 1       379/379
(100 %)
4 diff
(99.0 %id)
AI679905 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 1900 to 2276 377 to 1       377/377
(100 %)
0 diff
(100 %id)
AW340050 pooled .b 1900 to 2485 586 to 1       586/586
(100 %)
1 diff
(99.9 %id)
AW340301 pooled .b 1900 to 2474 585 to 11       575/585
(98 %)
0 diff
(100 %id)
AU144218 whole embryo, mainly head .b 1945 to 2484 537 to 1       537/554
(96 %)
11 diff
(98.1 %id)
BF434739 Kidney .b 1962 to 2485 524 to 1       524/524
(100 %)
1 diff
(99.9 %id)
N33558 melanocyte .b 2001 to 2486 489 to 1       489/491
(99 %)
9 diff
(98.2 %id)
AI678410 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 2004 to 2266 266 to 2       265/266
(99 %)
0 diff
(100 %id)
AV759247 bone marrow .b 2023 to 2457 1 to 428       428/434
(98 %)
9 diff
(98.0 %id)
AI383450 pooled .b 2070 to 2486 417 to 1       417/417
(100 %)
1 diff
(99.8 %id)
BU600177 mixed (pool of 40 RNAs) .b 2079 to 2858 1 to 784       784/786
(99 %)
14 diff
(98.3 %id)
N20649 melanocyte .b 2109 to 2485 378 to 1       378/378
(100 %)
4 diff
(99.0 %id)
CA453533 mixed (pool of 40 RNAs) .b 2115 to 2774 1 to 675       675/799
(84 %)
18 diff
(97.8 %id)
AA885057 pooled .b 2147 to 2491 345 to 1       345/345
(100 %)
0 diff
(100 %id)
BG925869 cartilage .b 2232 to 2678 86 to 532       447/536
(83 %)
3 diff
(99.5 %id)
DB324109   .b 2250 to 2787 542 to 4       539/542
(99 %)
0 diff
(100 %id)
CN337873 embryonic stem cells, DMSO-treated H9 cellline .b 2258 to 2651 1 to 394       394/405
(97 %)
4 diff
(99.1 %id)
BI260513 cervical carcinoma cell line, cervix .b 2267 to 2946 1 to 692       692/692
(100 %)
22 diff
(96.9 %id)
GD145094   .b 2272 to 2485 1 to 214   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 214/214
(100 %)
6 diff
(97.2 %id)
CX788123 human embryonic stem cells .b 2306 to 3055 1 to 750       750/750
(100 %)
2 diff
(99.8 %id)
CN337869 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2313 to 2962 1 to 650       650/650
(100 %)
3 diff
(99.6 %id)
DA472343   .b 2335 to 2864 2 to 533   tiling clone, capped   532/532
(100 %)
2 diff
(99.7 %id)
AI963349 adenocarcinoma, Pancreas .b 2355 to 2812 467 to 10       458/467
(98 %)
0 diff
(100 %id)
FN157324 breast carcinoma .b 2367 to 2491 125 to 1     Submitted on the opposite strand 125/125
(100 %)
3 diff
(97.6 %id)
CD516897 White Matter .b 2371 to 2868 1 to 501       501/870
(57 %)
13 diff
(98.6 %id)
DB376448 placenta .b 2411 to 2970 559 to 7       553/563
(98 %)
0 diff
(100 %id)
BF838126 head_neck .b 2418 to 2892 488 to 14     Submitted on the opposite strand 475/488
(97 %)
16 diff
(96.8 %id)
CN337871 embryonic stem cells, cell lines H1, H7, andH9 .b 2439 to 3104 1 to 667       667/667
(100 %)
6 diff
(99.2 %id)
AF088000 melanocyte .b 2448 to 2969 1 to 522   fully sequenced, AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 522/522
(100 %)
2 diff
(99.7 %id)
H43337 breast .b 2456 to 2778 325 to 1       325/325
(100 %)
4 diff
(98.8 %id)
N25858 melanocyte .b 2478 to 2824 1 to 350       350/350
(100 %)
6 diff
(98.3 %id)
BF184401 bone marrow, from chronic myelogenous leukemia .b 2480 to 3212 1 to 746       746/746
(100 %)
76 diff
(89.9 %id)
DN601558 human embryonic stem cells .b 2490 to 3235 1 to 745       745/745
(100 %)
2 diff
(99.8 %id)
AI446114 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 2507 to 2969 463 to 1       463/463
(100 %)
5 diff
(99.0 %id)
AW516974 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 2525 to 2982 454 to 2       453/454
(99 %)
0 diff
(100 %id)
AA171477   .b 2540 to 2969 425 to 1       425/426
(99 %)
7 diff
(98.4 %id)
BG167048 hypernephroma, cell line, Kidney .b 2542 to 3350 1 to 803       803/832
(96 %)
31 diff
(96.3 %id)
AL551840 placenta, Placenta Cot 25-normalized .b 2543 to 3628 1098 to 24       1075/1142
(94 %)
0 diff
(100 %id)
AI754119 bone marrow stroma .b 2565 to 2969 430 to 27   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 404/404
(100 %)
1 diff
(99.8 %id)
AW071550 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .b 2566 to 2962 411 to 15   AAA Possibly primed on the genome, locally A rich (28/32 A in genome downstream of last aligned base) 397/397
(100 %)
0 diff
(100 %id)
AI174576   .b 2582 to 3001 422 to 5       418/422
(99 %)
0 diff
(100 %id)
BG939483 bone marrow stroma .b 2615 to 2976 381 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 363/363
(100 %)
5 diff
(98.7 %id)
AI625078 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 2615 to 2969 362 to 13   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 350/350
(100 %)
5 diff
(98.6 %id)
BI495796 cochlea, ear .b 2640 to 2715 1 to 76   fully sequenced, AAA   76/76
(100 %)
5 diff
(93.5 %id)
BG928430 cartilage .b 2645 to 3192 88 to 635       548/567
(96 %)
6 diff
(99.0 %id)
CN337881 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2646 to 2935 1 to 284       284/284
(100 %)
4 diff
(98.6 %id)
AA321088 adipose tissue, brown .b 2647 to 2962 316 to 1       316/316
(100 %)
1 diff
(99.7 %id)
BI495795 cochlea, ear .b 2685 to 2993 317 to 11   fully sequenced,   307/317
(96 %)
6 diff
(98.2 %id)
AL517263 brain, neuroblastoma, neuroblastoma cells .b 2696 to 3668 969 to 1       969/1071
(90 %)
8 diff
(99.3 %id)
BF105093 Kidney .b 2708 to 3309 1 to 608       608/974
(62 %)
20 diff
(98.0 %id)
N20247 melanocyte .b 2732 to 2970 240 to 1   fully sequenced, Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 240/240
(100 %)
0 diff
(100 %id)
DT220321 brain .b 2807 to 3325 1 to 520       520/520
(100 %)
2 diff
(99.7 %id)
R53196 breast .b 2820 to 2963 1 to 144       144/144
(100 %)
0 diff
(100 %id)
H25013 breast .b 2820 to 2963 1 to 145       145/145
(100 %)
1 diff
(99.4 %id)
BG109624 Bone, osteosarcoma, cell line .b 2845 to 3629 1 to 780       780/926
(84 %)
19 diff
(98.0 %id)
BQ346374 nervous_tumor .b 2862 to 3222 347 to 1       347/347
(100 %)
34 diff
(90.3 %id)
AV658641 corresponding non cancerous liver tissue .b 2876 to 3275 1 to 400     Submitted on the opposite strand 400/400
(100 %)
0 diff
(100 %id)
AV658787 corresponding non cancerous liver tissue .b 2876 to 3536 1 to 660     Submitted on the opposite strand 660/660
(100 %)
12 diff
(98.2 %id)
BE886872 leiomyosarcoma, uterus .b 2886 to 3534 1 to 647       647/907
(71 %)
4 diff
(99.6 %id)
CN337878 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2897 to 3533 1 to 637       637/637
(100 %)
0 diff
(100 %id)
CD677516 eye, Trabecular meshwork .b 2921 to 3476 1 to 556       556/556
(100 %)
0 diff
(100 %id)
BQ346368 nervous_tumor .b 2981 to 3222 243 to 1       243/336
(72 %)
3 diff
(99.2 %id)
BQ446964 Knee, Osteoarthritic Cartilage .b 2987 to 3685 717 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 699/699
(100 %)
0 diff
(100 %id)
CA314657 Human Lung Epithelial cells, lung .b 2989 to 3691 721 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 703/703
(100 %)
0 diff
(100 %id)
BE769300 prostate_tumor .b 2991 to 3099 13 to 122       110/130
(84 %)
6 diff
(95.4 %id)
BF791563 adrenal cortex carcinoma, cell line, adrenal gland .b 2992 to 3692 1 to 706       706/722
(97 %)
24 diff
(96.7 %id)
CN337867 embryonic stem cells, DMSO-treated H9 cellline .b 3003 to 3747 1 to 745   tiling clone,   745/747
(99 %)
2 diff
(99.8 %id)
BQ573813 Chondrosarcoma Grade II, Left Pelvis .b 3006 to 3685 698 to 19   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 680/680
(100 %)
1 diff
(99.9 %id)
D58247   .b 3016 to 3405 1 to 389       389/389
(100 %)
1 diff
(99.8 %id)
FN046590 breast carcinoma .b 3039 to 3148 109 to 1     Submitted on the opposite strand 109/109
(100 %)
2 diff
(98.2 %id)
N28876 melanocyte .b 3043 to 3434 1 to 392       392/392
(100 %)
5 diff
(98.8 %id)
BQ024914 placenta .b 3071 to 3675 633 to 30   AAA   604/615
(98 %)
0 diff
(100 %id)
R71271 placenta .b 3089 to 3440 1 to 357   fully sequenced,   357/357
(100 %)
1 diff
(99.8 %id)
AI307256 2 pooled tumors (clear cell type), Kidney .b 3108 to 3686 592 to 16   AAA Possibly primed on the genome, locally A rich (16/18 A in genome downstream of last aligned base) 577/577
(100 %)
6 diff
(99.0 %id)
BX332932 Neuroblastoma Cot 25-normalized .b 3114 to 3693 1 to 580       580/580
(100 %)
0 diff
(100 %id)
AU152242   .b 3147 to 3683 536 to 3       534/537
(99 %)
0 diff
(100 %id)
H25014 breast .b 3343 to 3668 332 to 1       332/356
(93 %)
10 diff
(97.2 %id)
R53102 breast .b 3365 to 3691 336 to 1       336/338
(99 %)
15 diff
(95.6 %id)
R71224 placenta .b 3410 to 3670 261 to 1   fully sequenced,   261/261
(100 %)
0 diff
(100 %id)
DB366186   .b 3640 to 4215 571 to 1   tiling clone,   571/574
(99 %)
12 diff
(98.0 %id)
DR422994 eye, Pterygium .c 1 to 728 1 to 727   tiling clone,   727/727
(100 %)
8 diff
(98.9 %id)
TI_1948124676   .c 70 to 879 128 to 942       815/1387
(58 %)
21 diff
(98.5 %id)
TI_1948125211   .c 70 to 852 125 to 911       787/1358
(57 %)
24 diff
(98.3 %id)
BX641878   .c 71 to 701 1 to 631       631/631
(100 %)
1 diff
(99.9 %id)
CV023963 mixed .c 72 to 724 1 to 653       653/653
(100 %)
0 diff
(100 %id)
TI_1948124675   .c 72 to 881 127 to 938   tiling clone,   812/1449
(56 %)
19 diff
(98.7 %id)
CD630915   .c 88 to 642 27 to 581       555/584
(95 %)
12 diff
(98.0 %id)
CD630916   .c 88 to 668 581 to 1       581/592
(98 %)
2 diff
(99.7 %id)
CD521850 pooled .c 97 to 858 1 to 771       771/900
(85 %)
29 diff
(96.8 %id)
CD639571 pooled .c 100 to 811 1 to 706       706/743
(95 %)
15 diff
(98.0 %id)
BE884331 leiomyosarcoma, uterus .c 158 to 881 1 to 729       729/791
(92 %)
23 diff
(97.1 %id)
BQ027432 mixed .c 812 to 1147 350 to 15   tiling clone, AAA   336/336
(100 %)
0 diff
(100 %id)
CD241866 Blood vessels - aorta, basilar and artery .d-u 1 to 660 1 to 659   tiling clone,   659/660
(99 %)
3 diff
(99.6 %id)
N78518 multiple sclerosis lesions .d-u 388 to 983 1 to 606       606/612
(99 %)
25 diff
(96.0 %id)
BX090540 multiple sclerosis lesions .d-u 391 to 1016 1 to 626       626/627
(99 %)
2 diff
(99.7 %id)
CA442255 lung, Lung Focal Fibrosis .d-u 577 to 1180 12 to 614   tiling clone, Submitted on the opposite strand 603/614
(98 %)
2 diff
(99.7 %id)
CA432426 cell lines, Chondrosarcoma .d-u 752 to 1441 708 to 19   AAA   690/690
(100 %)
1 diff
(99.9 %id)
BQ015711 lung, Metastatic Chondrosarcoma .d-u 760 to 1399 1 to 641     Submitted on the opposite strand 641/641
(100 %)
1 diff
(99.9 %id)
CD676581 eye, Trabecular meshwork .d-u 808 to 1410 1 to 603       603/603
(100 %)
0 diff
(100 %id)
CB243268 Human Lung Epithelial cells, lung .d-u 906 to 1441 554 to 19   AAA   536/538
(99 %)
4 diff
(99.3 %id)
AW996707 breast_normal .d-u 938 to 1354 418 to 1     Submitted on the opposite strand 418/418
(100 %)
8 diff
(98.1 %id)
AI634137 pooled germ cell tumors .d-u 977 to 1441 465 to 1       465/465
(100 %)
1 diff
(99.8 %id)
AW470758 2 pooled tumors (clear cell type), Kidney .d-u 999 to 1444 450 to 5   tiling clone,   446/450
(99 %)
0 diff
(100 %id)
AW002404 pooled germ cell tumors .d-u 1001 to 1443 443 to 1       443/443
(100 %)
0 diff
(100 %id)
CA314732 Human Lung Epithelial cells, lung .d-u 1007 to 1441 455 to 19   AAA   437/456
(95 %)
7 diff
(98.5 %id)
BI494567 cochlea, ear .d-u 1023 to 1441 1 to 419   fully sequenced, AAA   419/419
(100 %)
5 diff
(98.9 %id)
AA738301 pooled germ cell tumors .d-u 1038 to 1441 404 to 1       404/404
(100 %)
0 diff
(100 %id)
BI494566 cochlea, ear .d-u 1068 to 1441 391 to 18   fully sequenced, AAA   374/374
(100 %)
0 diff
(100 %id)
N73676 multiple sclerosis lesions .d-u 1483 to 1619 137 to 1   tiling clone,   137/139
(98 %)
0 diff
(100 %id)
TI_149305513   .e 1 to 796 883 to 88 P2X G17V S18L S19L Q20S ... tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 796/972
(81 %)
7 diff
(99.3 %id)
BU685857 lung, Primary Lung Epithelial Cells .e 68 to 796 747 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 729/729
(100 %)
1 diff
(99.9 %id)
DB461299 testis .f 1 to 484 1 to 478   tiling clone,   478/478
(100 %)
3 diff
(99.4 %id)
DB461314 testis .f 1 to 483 1 to 477       477/477
(100 %)
3 diff
(99.4 %id)
DB093077 testis .f 2 to 562 2 to 557 exact tiling clone, capped   556/556
(100 %)
5 diff
(99.2 %id)
DA546233   .g 1 to 580 2 to 583   tiling clone, capped   582/582
(100 %)
3 diff
(99.5 %id)
DB318221   .g 2329 to 2647 575 to 257   tiling clone,   319/575
(55 %)
0 diff
(100 %id)
CN272137 embryonic stem cells, DMSO-treated H9 cellline .h-u 1 to 738 1 to 737   tiling clone,   737/737
(100 %)
4 diff
(99.5 %id)
BF983202 duodenal adenocarcinoma, cell line, small intestine .h-u 155 to 848 1 to 694       694/705
(98 %)
11 diff
(98.5 %id)
BM722390 eye, fetal eye .h-u 329 to 923 1 to 595 exact tiling clone, to resequence,   595/595
(100 %)
2 diff
(99.7 %id)
DB042726 testis .h-u 741 to 1314 2 to 574 I38M V39L I40Y L41F C42V ... tiling clone, capped   573/573
(100 %)
1 diff
(99.9 %id)
BQ228234 melanotic melanoma, skin .h-u 1612 to 2381 12 to 789   tiling clone,   778/911
(85 %)
22 diff
(97.6 %id)
BM678921 eye, fetal eye .h-u 1821 to 2487 685 to 19   to resequence, AAA   667/667
(100 %)
3 diff
(99.6 %id)
BX113212 multiple sclerosis lesions .h-u 1957 to 2487 1 to 531   AAA   531/531
(100 %)
1 diff
(99.9 %id)
DB337970 testis .h-u 1965 to 2487 524 to 1       524/524
(100 %)
2 diff
(99.7 %id)
BQ015482 placenta .h-u 2015 to 2487 490 to 18   AAA   473/473
(100 %)
0 diff
(100 %id)
AI307109 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h-u 2022 to 2487 466 to 1       466/477
(97 %)
5 diff
(99.0 %id)
DB543791 hippocampus .h-u 2037 to 2487 1 to 451     Submitted on the opposite strand 451/451
(100 %)
2 diff
(99.6 %id)
AI984409 Kidney .h-u 2072 to 2487 416 to 1       416/416
(100 %)
1 diff
(99.8 %id)
AW070682 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .h-u 2072 to 2488 418 to 2   tiling clone,   417/418
(99 %)
0 diff
(100 %id)
N50912 multiple sclerosis lesions .h-u 2082 to 2488 409 to 1       409/433
(94 %)
3 diff
(99.4 %id)
BQ015432 placenta .h-u 2123 to 2487 382 to 18   AAA   365/365
(100 %)
0 diff
(100 %id)
AW510987 pooled .h-u 2132 to 2488 359 to 3       357/359
(99 %)
0 diff
(100 %id)
BU634031 cell lines, Chondrosarcoma .h-u 2255 to 2487 251 to 19   AAA   233/237
(98 %)
0 diff
(100 %id)
AV708978 adrenal gland Gene SAV1, variant not shown         This clone was ignored    
AK095903   Gene SAV1, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
AK290883   Gene SAV1, variant not shown         Suspected internal deletion, this clone was ignored    
DB303380 amygdala Gene SAV1, variant not shown         This clone was ignored    
DA191274 amygdala Gene SAV1, variant not shown       capped This clone was ignored    
DB304501 brain Gene SAV1, variant not shown              
DA212659 brain Gene SAV1, variant not shown       capped      
CF272580   Gene SAV1, variant not shown         Suspected internal deletion, this clone was ignored    
CR741130   Gene SAV1, variant not shown         Suspected internal deletion, this clone was ignored    
AL551872 placenta, Placenta Cot 25-normalized Gene SAV1, variant not shown         Suspected internal deletion, this clone was ignored    
DB316219 brain Gene SAV1, variant not shown              
DA508767 brain Gene SAV1, variant not shown       capped      
AV661848 corresponding non cancerous liver tissue Gene SAV1, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
DB318532   Gene SAV1, variant not shown         Suspected internal deletion, this clone was ignored    
DA558151   Gene SAV1, variant not shown       capped Suspected internal deletion, this clone was ignored    
AV724862 hypothalamus Gene SAV1, variant not shown         Suspected internal deletion, this clone was ignored    
AA463189   Gene SAV1, variant not shown         Suspected internal deletion, this clone was ignored    
AA463276   Gene SAV1, variant not shown         Suspected internal deletion, this clone was ignored    
AI202300 Prostate Gene SAV1, variant not shown         Suspected internal deletion, this clone was ignored    
BC006385 Muscle, rhabdomyosarcoma Gene SAV1, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
BF205478 muscle, rhabdomyosarcoma Gene SAV1, variant not shown       available from MGC, Suspected internal deletion, this clone was ignored    
BG706149 brain, hypothalamus Gene SAV1, variant not shown         Suspected internal deletion, this clone was ignored    
CX867509 embryonic stem Gene SAV1, variant not shown       AAA This clone was ignored    
CX867592 embryonic stem Gene SAV1, variant not shown         This clone was ignored    
DA656412   Gene SAV1, variant not shown       capped Suspected internal deletion, this clone was ignored    
BP338345 Spleen Gene SAV1, variant not shown         This clone was ignored    
BQ025381 placenta Gene SAV1, variant not shown         This clone was ignored    
BQ025458 placenta Gene SAV1, variant not shown         This clone was ignored    
BQ023077 placenta Gene SAV1, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d-u, .e, .f, .g, .h-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI